Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdi ...

MEDNAX, Inc. (NYSE:MD) Q2 2020 Earnings Conference Call July 30, 2020 10:00 AM ET Company Participants Charles Lynch - Investor Relations Mark Ordan - Chief Executive Officer Stephen Farber - Chief Financial Officer Conference Call Participants A.J. Rice - Cr??dit Suisse Ralph Giacobbe - Citi Kevin Fischbeck - Bank of America Nick Spiekhout - William Blair Pito Chickering - Deutsche Bank Brian Tanquilut ??? Jefferies Rishi Parekh - Barclays Whit Mayo - UBS Operator Ladies and gentlemen, thank you for standi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdiction ...

MEDNAX, Inc. (NYSE:MD) Q1 2020 Earnings Conference Call May 7, 2020 10:00 AM ET Company Participants Charles Lynch - IR Roger Medel - CEO Stephen Farber - CFO Conference Call Participants Ralph Giacobbe - Citi A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Gary Taylor - JP Morgan Matthew Borsch - BMO Capital Markets Ryan Daniels - William Blair Kevin Fischbeck - Bank of America Jason Plagman - Jefferies Whit Mayo - UBS Operator Ladies and gentlemen, thank you for standing by. Welcome to the MEDNA ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or oth ...

MEDNAX, Inc. (NYSE:MD) Q4 2019 Earnings Conference Call February 20, 2020 9:00 AM ET Company Participants Charles Lynch – Vice President, Strategy and Investor Relations Roger Medel – Chief Executive Officer Stephen Farber – Chief Financial Officer Conference Call Participants Ralph Giacobbe – Citi A.J. Rice – Credit Suisse Seth Canetto – Stifel Rishi Parekh – Barclays Kevin Fischbeck – Bank of America Merrill Lynch Whit Mayo – UBS Gary Taylor – JPMorgan Jason Plagman – Jefferies Pito Chickering – Deutsche ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction of inco ...

1 Bank of America Merrill Lynch 2019 Leveraged Finance Conference Charles Lynch Vice President, Strategy and Investor Relations මු Forward looking disclosure Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but ar ...

MEDNAX, Inc. (NYSE:MD) Q3 2019 Earnings Conference Call November 1, 2019 9:00 AM ET Company Participants Charles Lynch - Vice President-Strategy and Investor Relations Roger Medel - Chief Executive Officer Stephen Farber - Chief Financial Officer Conference Call Participants AJ Rice - Credit Suisse Ralph Giacobbe - Citi Chad Vanacore - Stifel Pito Chickering - Deutsche Bank Jason Plagman - Jefferies Kevin Fischbeck - Bank of America Gary Taylor - JP Morgan Whit Mayo - UBS Operator Ladies and gentlemen, than ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of Incorporation or organizatio ...